You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Relvar Ellipta 92/22mcg and 185/92mcg pack shot

Product overview

Relvar Ellipta is an ICS/LABA combination for the treatment of asthma and COPD [1] [2]. Relvar is the only ICS/LABA which is one inhalation, once daily which delivers 24 hours of continuous efficacy.

*SMC= Scottish Medicines Consortium

ǂ AWMSG= All Wales Medicines Strategy Group

Innoviva logo

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

Relvar and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies